Gene expression profiles of murine fatty liver induced by the administration of methotrexate

Toxicology

Volumn 249, Issue 1, 2008, Pages 75-84

  Lee, Min Ho ^a   Hong, Il ^a   Kim, Mingoo ^b,f   Lee, Byung Hoon ^a,f   Kim, Ju Han ^b,f   Kang, Kyung Sun ^c,f   Kim, Hyung Lae ^d,f   Yoon, Byung Il ^e,f   Chung, Heekyoung ^f   Kong, Gu ^f   Lee, Mi Ock ^a,f  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Ewha Womans University   (South Korea)

^e Kangwon National University   (South Korea)

^f Hanyang University   (South Korea)

Author keywords

Fatty liver; Methotrexate; Microarray analysis; Toxicogenomics

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; METHOTREXATE; TRIACYLGLYCEROL;

ANIMAL TISSUE; ARTICLE; CATABOLISM; FATTY LIVER; GENE EXPRESSION; GENE IDENTIFICATION; HISTOPATHOLOGY; LIPID METABOLISM; LIPID TRANSPORT; LIVER TOXICITY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; RISK ASSESSMENT; STEATOSIS;

ADMINISTRATION, ORAL; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION PROFILING; LIPID METABOLISM; MALE; METHOTREXATE; MICE; MICE, INBRED ICR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TOXICOGENETICS;

ANIMALIA; MURINAE; MUS;

EID: 44649091222     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.04.011     Document Type: Article

References (45)

1. Ahern M.J., Smith M.D., and Roberts-Thomson P.J. Methotrexate hepatotoxicity: what is the evidence?. Inflamm. Res. 47 (1998) 148-151
2. Aquerreta I., Aldaz A., Giráldez J., and Sierrasesúmaga L. Methotrexate pharmacokinetics and survival in osteosarcoma. Pediatr. Blood Cancer. 42 (2004) 52-58
3. Bolstad B.M., Irizarry R.A., Astrand M., and Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 (2003) 185-193
4. Breithaupt H., and Küenzlen E. High-dose methotrexate for osteosarcoma: toxicity and clinical results. Oncology 40 (1983) 85-89
5. Chan K.K., Nayar M.S., Cohen J.L., Chlebowski R.T., Liebman H., Stolinsky D., Mitchell M.S., and Farquhar D. Metabolism of methotrexate in man after high and conventional doses. Res. Commun. Chem. Pathol. Pharmacol. 28 (1980) 551-561
6. Chang B.H., Li L., Paul A., Taniguchi S., Nannegari V., Heird W.C., and Chan L. Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol. Cell Biol. 26 (2006) 1063-1076
7. Chiappini F., Barrier A., Saffroy R., Domart M.C., Dagues N., Azoulay D., Sebagh M., Franc B., Chevalier S., Debuire B., Dudoit S., and Lemoine A. Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray. Lab. Invest. 86 (2006) 154-165
8. Deboyser D., Goethals F., and Roberfroid M. Biochemical effects of methotrexate in isolated hepatocytes in relation to its steatogenic activity. Toxicol. In Vitro 6 (1992) 129-132
9. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., and Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 4 (2003) P3
10. Foger B., Santamarina-Fojo S., Shamburek R.D., Parrot C.L., Talley G.D., and Brewer Jr. H.B. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J. Biol. Chem. 272 (1997) 27393-27400
11. Genestier L., Paillot R., Quemeneur L., Izeradjene K., and Revillard J.P. Mechanisms of action of methotrexate. Immunopharmacology 47 (2000) 247-257
12. Geng Y., Lee Y.M., Welcker M., Swanger J., Zagozdzon A., Winer J.D., Roberts J.M., Kaldis P., Clurman B.E., and Sicinski P. Kinase-independent function of cyclin E. Mol. Cell 25 (2007) 127-139
13. Gorczyca W., Bruno S., Melamed M.R., and Darzynkiewicz Z. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide. Cancer Res. 52 (1992) 3491-3494
14. Huang Q., Jin X., Gaillard E.T., Knight B.L., Pack F.D., Stoltz J.H., Jayadev S., and Blanchard K.T. Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. Mutat. Res. 549 (2004) 147-167
15. Huber W., von Heydebreck A., Sultmann H., Poustka A., and Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (2002) S96-S104
16. Huennekens F.M. The methotrexate story: a paradigm for development of cancer chemotherapeutic agents. Adv. Enzyme Regul. 34 (1994) 397-419
17. Jensen M.R., Factor V.M., Fantozzi A., Helin K., Huh C.G., and Thorgeirsson S.S. Reduced hepatic tumor incidence in cyclin G1-deficient mice. Hepatology 37 (2003) 862-870
18. Jogl G., Hsiao Y.S., and Tong L. Structure and function of carnitine acyltransferases. Ann. NY Acad. Sci. 1033 (2004) 17-29
19. Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf. 24 (2001) 483-490
20. Kevat S., Ahern M., and Hall P. Hepatotoxicity of methotrexate in rheumatic diseases. Med. Toxicol. Adverse Drug Exp. 3 (1988) 197-208
21. Ko M.A., Rosario C.O., Hudson J.W., Kulkarni S., Pollett A., Dennis J.W., and Swallow C.J. Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nat. Genet. 37 (2005) 883-888 Epub 2005
22. Langman G., Hall P.M., and Todd G. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. J. Gastroenterol. Hepatol. 16 (2001) 1395-1401
23. Lee M.H., Hong I., Kim M., Lee B.H., Kim J.H., Kang K.S., Kim H.L., Yoon B.I., Chung H., Kong G., and Lee M.O. Gene expression profiles of murine fatty liver induced by the administration of valproic acid. Toxicol. Appl. Pharmacol. 220 (2007) 45-59
24. Lee M.H., Kim M., Lee B.H., Kim J.H., Kang K.S., Kim H.L., Yoon B.I., Chung H., Kong G., and Lee M.O. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver. Toxicol. Appl. Pharmacol. 226 (2007) 271-284
25. Lindquist S., and Craig E.A. The heat-shock proteins. Annu. Rev. Genet. 22 (1988) 631-677
26. Massiera F., Seydoux J., Geloen A., Quignard-Boulange A., Turban S., Saint-Marc P., Fukamizu A., Negrel R., Ailhaud G., and Teboul M. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 142 (2001) 5220-5225
27. Mi H., Lazareva-Ulitsky B., Loo R., Kejariwal A., Vandergriff J., Rabkin S., Guo N., Muruganujan A., Doremieux O., Campbell M.J., Kitano H., and Thomas P.D. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res. 33 (2005) D284-D288
28. Nuwaysir E.F., Bittner M., Trent J., Barrett J.C., and Afshari C.A. Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinogen. 24 (1999) 153-159
29. Ogata H., Goto S., Sato K., Fujibuchi W., Bono H., and Kanehisa M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 27 (1999) 29-34
30. Richard S., Guerret S., Gerard F., Tebib J.G., and Vignon E. Hepatic fibrosis in rheumatoid arthritis patients treated with methotrexate: application of a new semi-quantitative scoring system. Rheumatology (Oxford) 39 (2000) 50-54
31. Risley J.M. Cholesterol biosynthesis: lanosterol to cholesterol. J. Chem. Educ. 79 (2002) 377-384
32. Roenigk Jr. H.H., Auerbach R., Maibach H.I., and Weinstein G.D. Methotrexate in psoriasis: revised guidelines. J. Am. Acad. Dermatol. 19 (1988) 145-156
33. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374-378
34. Shakoori A.R., Oberdorf A.M., Owen T.A., Weber L.A., Hickey E., Stein J.L., Lian J.B., and Stein G.S. Expression of heat shock genes during differentiation of mammalian osteoblasts and promyelocytic leukemia cells. J. Cell Biochem. 48 (1992) 277-287
35. Song C.W., Ha C.S., and Han S.S. A study on basic data of Ktc: ICR mice with age. Korea J. Lab. Anim. Sci. 5 (1989) 59-68
36. Steinley D. K-means clustering: a half-century synthesis. Br. J. Math. Stat. Psychol. 59 (2006) 1-34
37. Swierkot J., and Szechinski J. Methotrexate in rheumatoid arthritis. Pharmacol. Rep. 58 (2006) 473-492
38. Troyanskaya O., Cantor M., Sherlock G., Brown P., Hastie T., Tibshirani R., Botstein D., and Altman R.B. Missing value estimation methods for DNA microarrays. Bioinformatics 17 (2001) 520-525
39. Tvrdik P., Westerberg R., Silve S., Asadi A., Jakobsson A., Cannon B., Loison G., and Jacobsson A. Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids. J. Cell Biol. 149 (2000) 707-718
40. Waring J.F., Ciurlionis R., Jolly R.A., Heindel M., and Ulrich R.G. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120 (2001) 359-368
41. Waring J.F., Jolly R.A., Ciurlionis R., Lum P.Y., Praestgaard J.T., Morfitt D.C., Buratto B., Roberts C., Schadt E., and Ulrich R.G. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 175 (2001) 28-42
42. Westerberg R., Mansson J.E., Golozoubova V., Shabalina I.G., Backlund E.C., Tvrdik P., Retterstol K., Capecchi M.R., and Jacobsson A. ELOVL3 is an important component for early onset of lipid recruitment in brown adipose tissue. J. Biol. Chem. 281 (2006) 4958-4968
43. Yin H.Q., Kim M., Kim J.H., Kong G., Lee M.O., Kang K.S., Yoon B.I., Kim H.L., and Lee B.H. Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline. Toxicol. Sci. 94 (2006) 206-216
44. Yin H.Q., Kim M., Kim J.H., Kong G., Kang K.S., Kim H.L., Yoon B.I., Lee M.O., and Lee B.H. Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicol. Appl. Pharmacol. 223 (2007) 225-233
45. Yoshida M., Niwa M., Ishisaki A., Hirade K., Ito H., Shimizu K., Kato K., and Kozawa O. Methotrexate enhances prostaglandin D2-stimulated heat shock protein 27 induction in osteoblasts. Prostaglandins Leukot. Essent. Fatty Acids 71 (2004) 351-362